Molecular fingerprints of drug-resistant epilepsy identified through liquid biopsy profiling.
Liquid biopsy technology offers a non-invasive way to identify the underlying biology driving drug-resistant epilepsy.
This review examines molecular fingerprints of drug-resistant epilepsy identifiable through liquid biopsy. It highlights the expanding non-oncology applications of liquid biopsy technology.
What the study was
- Study design
- Review
- Population
- Patients with drug-resistant epilepsy
- Category
- Diagnostics
- Maturity
- Exploratory
- Journal
- Drug Discovery Today
Why it surfaced
Interesting non-oncology liquid biopsy application for epilepsy. Review format, tangential to primary watchlist focus on cancer.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.